Library / Hormonal / Prostamax
Prostate bioregulator
Prostamax
Bioregulator
ClassKhavinson peptide
Typical routes in papersOral
Half-life contextShort
EvidenceRussian bioregulator literature
What it is
Prostamax is the prostate-targeted short peptide in the same catalog.
Benefits in plain language
What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.
- Pitched for age-related prostate comfort and urinary flow talk.
- Not a replacement for PSA workups or 5-ARI / alpha-blocker medicine.
- Archive completeness, not a treatment claim.
If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.
Mechanism of action
Claimed prostate-tissue expression modulation.
Possible side effects / caveats
Delaying real urology care is the worst side effect of any “prostate peptide” story.
Protocol ranges
| Source tier | Amount | Frequency / duration | Notes |
|---|---|---|---|
| Cited courses | 1–2 mg class | Cycled oral | Tradition |
Numbers below and above are literature or community pointers, not a treatment plan. Approved products, when they exist, follow the official label — not a research vial.